Workflow
TATA健康(01255) - 2019 - 年度财报
TATA HEALTHTATA HEALTH(HK:01255)2020-04-28 08:48

Financial Performance - The company's revenue for the year ended December 31, 2019, was HKD 341,773,000, a decrease of 4.5% from HKD 358,006,000 in 2018[9] - Gross profit for the same period was HKD 199,473,000, down 9.5% from HKD 220,507,000 in 2018, resulting in a gross margin of 58.4%[9] - The company reported a loss before tax of HKD 67,446,000 compared to a profit of HKD 6,583,000 in the previous year[9] - The footwear business generated revenue of approximately HKD 270,100,000, a decline of 20.1% year-on-year[15] - The health product business recorded revenue of approximately HKD 51,600,000, showing significant growth compared to the previous year[15] - Revenue from the financial services segment was approximately HKD 20,200,000 for the year[15] - The company's total revenue for the year was HKD 341,800,000, a decrease of 4.5% compared to HKD 358,000,000 in the previous year[31] - The footwear business experienced a significant decline, with a revenue drop of HKD 67,900,000, leading to a same-store sales decline of approximately 12.3%[21] - The health business revenue increased to HKD 51,600,000 from HKD 1,100,000 in the previous year, indicating a substantial growth[23] - The financial services segment recorded revenues of HKD 20,200,000 and HKD 30,100,000, with a goodwill impairment of HKD 27,100,000 impacting the segment's performance[24] - The group reported a pre-tax loss of HKD 67,400,000 for the year, compared to a pre-tax profit of HKD 6,600,000 in 2018[48] Financial Ratios and Metrics - The company achieved a current ratio of 2.2 times, down from 2.4 times in 2018[10] - The total liabilities to equity ratio increased to 37.4% from 20.0% in the previous year[10] - The average inventory turnover period improved to 347.8 days from 389.2 days in 2018[10] - The asset-liability ratio as of December 31, 2019, was 37.4%, up from 20.0% in 2018, mainly due to an increase in non-current liabilities[52] - As of December 31, 2019, the group's cash and bank deposits were HKD 46,800,000, a 62.4% increase from HKD 28,800,000 in 2018[52] Strategic Initiatives - The company is focusing on expanding its online medical services and health business as part of its strategic transformation[16] - The company plans to expand into the Singapore market and optimize resources through internal restructuring in response to economic downturns[28] - The company aims to transform its business model by integrating online and offline services in the health sector, creating a comprehensive health industry chain[29] - The company is actively seeking strategic partnerships in the health industry to enhance its business ecosystem and create sustainable value for shareholders[29] - The company plans to continue merging businesses and seek strategic partners in the healthcare and online medical services sectors[58] Environmental, Social, and Governance (ESG) Efforts - The company has established a dedicated ESG task force to enhance employee awareness of environmental protection and social responsibility[84] - The ESG report aims to present a balanced view of the company's performance in environmental, social, and governance matters[76] - The company has implemented a comprehensive risk management and internal control system covering ESG risks[84] - The company achieved a 38% reduction in greenhouse gas emissions density during the reporting period[103] - The total electricity consumption for the year was 527,227 kWh, representing a 41% decrease in electricity consumption density[109] - Water consumption density decreased by 12%, with total water consumption recorded at 262 cubic meters[111] - The company has committed to reducing waste generated from its operations and is moving towards a paperless workplace[101] - The company has integrated green concepts into its internal management and daily operations to achieve sustainability goals[100] Corporate Governance - The company has maintained compliance with the corporate governance code since its listing on July 11, 2013, ensuring transparency and investor confidence[164] - The board is committed to monitoring and evaluating the effectiveness of its corporate governance framework[164] - The independent non-executive directors have extensive experience in accounting, law, and finance, contributing to the company's governance[156][159] - The company has established various committees, including audit, nomination, and remuneration committees, to ensure effective governance[156][159] - The board believes that good corporate governance practices are essential for maintaining and enhancing investor confidence[164] Employee and Community Engagement - The company donated over HKD 1,400,000 to various charitable organizations during the reporting period, demonstrating its commitment to social responsibility[138] - The healthcare division allows customers to return or exchange products free of charge within 7 days of delivery, regardless of the reason, enhancing consumer rights protection[130] - The company has established a rigorous supplier selection process, ensuring high standards in quality control, service, and environmental protection[129] - The total training hours for employees during the reporting period amounted to approximately 1,040 hours, aimed at enhancing productivity and efficiency[126] Future Outlook - The company has outlined a future outlook with a projected revenue growth of 20% for the upcoming fiscal year[150] - New product launches are expected to contribute an additional $50 million in revenue, with a focus on innovative technology solutions[151] - The company is planning to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[152] - A strategic acquisition is in progress, which is anticipated to enhance the company's asset management capabilities and increase overall market competitiveness[146]